Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV caffeine, dexamethasone, and aminophylline for prevention of headache after spinal anesthesia in cesarean section
IRCT20251121068066N6Phase 2Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of caffeine, dexamethasone and aminophylline in post-dural puncture headache (PDPH) (4 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoint: Post-spinal anesthesia headache severity. Started May 2025; status: completed.
02
Drugs
caffeinedexamethasoneaminophylline
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20251121068066N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251121068066N6.